Skip to main content

Table 4 Significant correlations between remarkable intra-network functional clusters and neuropsychological tests or blood biochemical parameters

From: Improved cognition after rifaximin treatment is associated with changes in intra- and inter-brain network functional connectivity

Network

Cluster

Psychometric tests

R

p value

Left fronto-parietal network

LFPN-1

PHES

− 0.595

0.046

DST (items completed)

− 0.583

0.046

NCT-A (seconds)

0.708

0.015

Oral SDMT (correct pairings)

− 0.668

0.019

Oral SDMT (total pairings)

− 0.6

0.019

LFPN-2

PHES

− 0.7

0.015

DST (items completed)

− 0.683

0.019

LTT (seconds + errors)

0.597

0.029

Stroop-neutral task

− 0.644

0.02

Stroop-incongruent task

− 0.592

0.034

Oral SDMT (correct pairings)

− 0.769

0.013

Oral SDMT (total pairings)

− 0.704

0.015

Lateral sensorimotor network

LSMN-1

DST (items completed)

− 0.69

0.018

Oral SDMT (correct pairings)

− 0.669

0.018

Network

Cluster

Biochemical parameter

R

p value

Left fronto-parietal network

LFPN-1

IL6

0.66

0.019

LFPN-2

IL6

0.815

 < 0.001

IL18

0.565

0.026

Mip3/CCL20

0.59

0.024

IL22

0.656

0.01

Lateral sensorimotor network

LSMN-1

IL6

0.663

0.009

IL18

0.524

0.046

IL22

0.755

0.002

IL15

0.511

0.046

Fractalkine/CX3CL1

0.519

0.046

LSMN-2

IL6

0.68

0.017

IL18

0.824

 < 0.001

Mip3/CCL20

0.711

0.017

CXCL13

0.66

0.018

IL22

0.607

0.032

IL15

0.689

0.017

Medial sensorimotor network

MSMN-1

Ammonia

0.55

0.03

IL6

− 0.709

0.003

IL22

− 0.715

0.003

IL15

− 0.597

0.021

  1. R and p from significant Spearman correlations are shown
  2. R, correlation coefficient. Correlations were considered significant at p < 0.05 after FDR correction
  3. Clusters are named as shown in Table 3